What is low-risk prostate cancer? Podcast Interview with Urologist, Mr Kevin Chu

Listen to urologist, Mr Kevin Chu talk about how prostate cancer is diagnosed, the tests involved and teasing out the differences in treatment pathways . Kevin is a train robotic surgeon with an interest in cancer and minimally invasive surgery.

Tag: Active Surveillance, Gleason score, grading, high-risk, intermediate-risk, Low-Risk, podcast, Prostate Cancer, Radiotherapy, staging, Surgery, Treatment, urologist

Category: Blog, Side Effects

Prostate Cancer Treatment Costs Explained

A prostate cancer diagnosis can be stressful, let alone thinking about treatment costs and the potential hit to your wallet. Here we provide an overview of out-of-pocket costs for localised, low-risk prostate cancer (which is early stage and slow growing) and provide some useful Australian resources on where to get financial help and support.

Tag: Costs, DVA, financial, Health insurance, legal, Medicare, Patient, policy, Private, Prostate Cancer, Public, radiation oncologist, Treatment option, urologist, Veterans

Category: Navigate Trial

Prostate Specific Antigen (PSA) Test for Prostate Cancer

The Prostate Specific Antigen (PSA) test is a simple blood test that measures the level of prostate specific antigen in the blood, and helps to detect and monitor prostate cancer. If you have recently had a PSA test or are considering having it done, here we provide an overview about what’s involved, the benefits and risks of having the test and where to go for more information from reliable Australian sources.

Tag: benign prostatic hyperplasia, Biopsy, BPH, Diagnosis, DRE, Prostate Cancer, prostate specific antigen, prostatitis, PSA, PSA level, Risks, Screening, signs & symptoms, Symptoms, urologist, UTI

Category: Navigate Trial

Prostate Cancer Grading and Staging | Explained by Australian Urologist Expert

Prostate cancer is the most common cancer affecting men in Australia. It is a cancer arising from the prostate gland which is located between the bladder and the penis, deep in the pelvis. Staging and grading is very important so doctors can ‘risk stratify’ men depending on whether their cancer is not very aggressive, aggressive or somewhere in between. So what do we mean by the terms Staging and Grading?…

Tag: Active Surveillance, Declan Murphy, Gleason score, grading, high-risk, intermediate-risk, Low-Risk, Prostate Cancer, Radiotherapy, staging, Surgery, Treatment, urologist

Category: Blog, Side Effects

Localised Prostate Cancer: To Treat or Not to Treat?

Men are distressed, confused and conflicted about the treatment options for early stage and non-aggressive prostate cancer. “Everybody’s got different ideas about it,” one man reported when talking about his diagnosis of localised, low risk prostate cancer…

Tag: Active Surveillance, Biopsy, Brachytherapy, curative treatment, early-stage, External beam radiotherapy, Localised prostate cancer, LRPC, management plan, Prostate Cancer, prostate specific antigen, prostatectomy, PSA blood test, radical treatment, Side-effects, urologist

Category: Navigate Trial

Prostate Cancer Diagnosis – A Partner’s Perspective

When Alan received his prostate cancer diagnosis in January 2011, I was utterly gobsmacked. I attended the urologist appointment with Alan to discuss his recent biopsy results, but we were fully expecting him to receive a clean bill of health.This is my personal story of prostate cancer diagnosis from a partner’s perspective…

Tag: Active Surveillance, Biopsy, Diagnosis, Erectile dysfunction, Help, Incontinence, Information, Partner, Prostate Cancer, Relationship, Side-effects, Support, Surgery, Treatment decision, urologist

Category: Blog, Partners and Carers, Wellness

Declan Murphy, Site Investigator at Peter Mac

It is with great pleasure we announce that Prof Declan Murphy, our Navigate Trial Principal Investigator at Peter Mac, has been promoted to Full Professor within the Sir Peter MacCallum Department of Oncology at the University of Melbourne, effective 1 April 2019.

Tag: Declan Murphy, GU Oncology, Low-Risk, Melbourne, Navigate, Peter MacCallum Cancer Centre, Prostate Cancer, prostatectomy, Public, Research, Robotic prostatectomy, Surgery, Treatment, urologist, Victoria

Category: Navigate Trial, News

What is low-risk prostate cancer? Podcast Interview with Urologist, Mr Kevin Chu

Prostate Cancer Treatment Costs Explained

Prostate Specific Antigen (PSA) Test for Prostate Cancer

Prostate Cancer Grading and Staging | Explained by Australian Urologist Expert

Localised Prostate Cancer: To Treat or Not to Treat?

Prostate Cancer Diagnosis – A Partner’s Perspective

Declan Murphy, Site Investigator at Peter Mac

Search

Recent Posts

Archives

Categories